These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3843353)

  • 1. Drugs inhibiting HMG-CoA reductase.
    Endo A
    Pharmacol Ther; 1985; 31(3):257-67. PubMed ID: 3843353
    [No Abstract]   [Full Text] [Related]  

  • 2. Compactin (ML-236B) and related compounds as potential cholesterol-lowering agents that inhibit HMG-CoA reductase.
    Endo A
    J Med Chem; 1985 Apr; 28(4):401-5. PubMed ID: 3981532
    [No Abstract]   [Full Text] [Related]  

  • 3. Lowering plasma cholesterol by raising LDL receptors.
    Brown MS; Goldstein JL
    N Engl J Med; 1981 Aug; 305(9):515-7. PubMed ID: 6265781
    [No Abstract]   [Full Text] [Related]  

  • 4. HMG-CoA reductase inhibitors.
    Endo A
    Adv Exp Med Biol; 1985; 183():295-310. PubMed ID: 4036702
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of ML-236b (compactin) on sterol synthesis and low density lipoprotein receptor activities in fibroblasts of patients with homozygous familial hypercholesterolemia.
    Haba T; Mabuchi H; Yoshimura A; Watanabe A; Wakasugi T; Tatami R; Ueda K; Ueda R; Kametani T; Koizumi J; Miyamoto S; Takeda R; Takeshita H
    J Clin Invest; 1981 May; 67(5):1532-40. PubMed ID: 7229037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypercholesterolemia persisting after distal ileal bypass: response to mevinolin.
    Illingworth DR; Connor WE
    Ann Intern Med; 1984 Jun; 100(6):850-1. PubMed ID: 6562870
    [No Abstract]   [Full Text] [Related]  

  • 7. Abnormal regulation of the LDL-R and HMG CoA reductase genes in subjects with familial hypercholesterolemia with the "French Canadian mutation".
    Yu L; Qiu S; Genest J
    Atherosclerosis; 1996 Jul; 124(1):103-17. PubMed ID: 8800498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum lipoprotein Lp(a) concentrations are not influenced by an HMG CoA reductase inhibitor.
    Thiery J; Armstrong VW; Schleef J; Creutzfeldt C; Creutzfeldt W; Seidel D
    Klin Wochenschr; 1988 May; 66(10):462-3. PubMed ID: 2969433
    [No Abstract]   [Full Text] [Related]  

  • 9. Mevinolin stimulates receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes.
    Bilheimer DW; Grundy SM; Brown MS; Goldstein JL
    Trans Assoc Am Physicians; 1983; 96():1-9. PubMed ID: 6388097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prediction of the therapeutic response to cholesterol lowering drugs in an 11-year-old boy with homozygous familial hypercholesterolaemia.
    Bakker HD; Bruin T; Schaap MC; Lansberg PJ; Kastelein JJ
    J Inherit Metab Dis; 1991; 14(3):389-92. PubMed ID: 1663193
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma mevalonic acid, an index of cholesterol synthesis in vivo, and responsiveness to HMG-CoA reductase inhibitors in familial hypercholesterolaemia.
    Naoumova RP; Marais AD; Mountney J; Firth JC; Rendell NB; Taylor GW; Thompson GR
    Atherosclerosis; 1996 Jan; 119(2):203-13. PubMed ID: 8808497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lowering plasma cholesterol by raising ldl receptors. 1981.
    Brown MS; Goldstein JL
    Atheroscler Suppl; 2004 Oct; 5(3):57-9. PubMed ID: 15531276
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypolipidemic effects of HMG-CoA reductase inhibitors in patients with hypercholesterolemia.
    Illingworth DR; Bacon S
    Am J Cardiol; 1987 Oct; 60(12):33G-42G. PubMed ID: 3314447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of HMG-CoA reductase, apoprotein-B and LDL receptor gene expression by the hypocholesterolemic drugs simvastatin and ciprofibrate in Hep G2, human and rat hepatocytes.
    Qin W; Infante J; Wang SR; Infante R
    Biochim Biophys Acta; 1992 Jul; 1127(1):57-66. PubMed ID: 1627634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.
    Pappu AS; Bacon SP; Illingworth DR
    J Lab Clin Med; 2003 Apr; 141(4):250-6. PubMed ID: 12677170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of cholesterol absorption by HMG-CoA reductase inhibitor.
    Miettinen TA
    Eur J Clin Pharmacol; 1991; 40 Suppl 1():S19-21. PubMed ID: 1904356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [HMG-CoA reductase inhibitors].
    Endo A
    Nihon Rinsho; 1991 Sep; 49(9):2004-9. PubMed ID: 1960868
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of CS-514 (eptastatin), an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, on serum lipid and apolipoprotein levels in heterozygous familial hypercholesterolemic patients treated by low density lipoprotein (LDL)-apheresis.
    Mabuchi H; Fujita H; Michishita I; Takeda M; Kajinami K; Koizumi J; Takeda R; Takegoshi T; Wakasugi T; Ueda K
    Atherosclerosis; 1988 Aug; 72(2-3):183-8. PubMed ID: 3145745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low density lipoprotein density and composition in hypercholesterolaemic men treated with HMG CoA reductase inhibitors and gemfibrozil.
    Tilly-Kiesi M; Tikkanen MJ
    J Intern Med; 1991 May; 229(5):427-34. PubMed ID: 2040869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors.
    Endo A
    Methods Enzymol; 1981; 72():684-9. PubMed ID: 7311861
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.